These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 35681209

  • 1. Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort.
    Wargny M, Croyal M, Ragot S, Gand E, Jacobi D, Trochu JN, Prieur X, Le May C, Goronflot T, Cariou B, Saulnier PJ, Hadjadj S, SURDIAGENE study group.
    Cardiovasc Diabetol; 2022 Jun 09; 21(1):101. PubMed ID: 35681209
    [Abstract] [Full Text] [Related]

  • 2. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
    Tang WH, Wang Z, Shrestha K, Borowski AG, Wu Y, Troughton RW, Klein AL, Hazen SL.
    J Card Fail; 2015 Feb 09; 21(2):91-6. PubMed ID: 25459686
    [Abstract] [Full Text] [Related]

  • 3. Association of gut-related metabolites with outcome in acute heart failure.
    Israr MZ, Bernieh D, Salzano A, Cassambai S, Yazaki Y, Heaney LM, Jones DJL, Ng LL, Suzuki T.
    Am Heart J; 2021 Apr 09; 234():71-80. PubMed ID: 33454370
    [Abstract] [Full Text] [Related]

  • 4. Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults.
    Fretts AM, Hazen SL, Jensen P, Budoff M, Sitlani CM, Wang M, de Oliveira Otto MC, DiDonato JA, Lee Y, Psaty BM, Siscovick DS, Sotoodehnia N, Tang WHW, Lai H, Lemaitre RN, Mozaffarian D.
    JAMA Netw Open; 2022 May 02; 5(5):e2213242. PubMed ID: 35594043
    [Abstract] [Full Text] [Related]

  • 5. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
    Amrein M, Li XS, Walter J, Wang Z, Zimmermann T, Strebel I, Honegger U, Leu K, Schäfer I, Twerenbold R, Puelacher C, Glarner N, Nestelberger T, Koechlin L, Ceresa B, Haaf P, Bakula A, Zellweger M, Hazen SL, Mueller C.
    Clin Res Cardiol; 2022 Jun 02; 111(6):692-704. PubMed ID: 35220448
    [Abstract] [Full Text] [Related]

  • 6. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M, Ueland T, Hov JR, Svardal A, Gregersen I, Dahl CP, Aakhus S, Gude E, Bjørndal B, Halvorsen B, Karlsen TH, Aukrust P, Gullestad L, Berge RK, Yndestad A.
    J Intern Med; 2015 Jun 02; 277(6):717-26. PubMed ID: 25382824
    [Abstract] [Full Text] [Related]

  • 7. Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.
    Lemaitre RN, Jensen PN, Wang Z, Fretts AM, McKnight B, Nemet I, Biggs ML, Sotoodehnia N, de Oliveira Otto MC, Psaty BM, Siscovick DS, Hazen SL, Mozaffarian D.
    JAMA Netw Open; 2021 Aug 02; 4(8):e2122844. PubMed ID: 34448864
    [Abstract] [Full Text] [Related]

  • 8. [Predictive value of plasma TMAO combined with NT-proBNP on the prognosis and length of hospitalization of patients with ischemic heart failure].
    Qiu WD, Xiao XJ, Xia S, Gao ZP, Li LW.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul 24; 50(7):684-689. PubMed ID: 35856225
    [Abstract] [Full Text] [Related]

  • 9. Surrogate markers of gut dysfunction are related to heart failure severity and outcome-from the BIOSTAT-CHF consortium.
    Israr MZ, Zhan H, Salzano A, Voors AA, Cleland JG, Anker SD, Metra M, van Veldhuisen DJ, Lang CC, Zannad F, Samani NJ, Ng LL, Suzuki T, BIOSTAT-CHF investigators (full author list as appendix).
    Am Heart J; 2022 Jun 24; 248():108-119. PubMed ID: 35278373
    [Abstract] [Full Text] [Related]

  • 10. Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria.
    Winther SA, Øllgaard JC, Hansen TW, von Scholten BJ, Reinhard H, Ahluwalia TS, Wang Z, Gæde P, Parving HH, Hazen S, Pedersen O, Rossing P.
    PLoS One; 2021 Jun 24; 16(3):e0244402. PubMed ID: 33657115
    [Abstract] [Full Text] [Related]

  • 11. Choline metabolites and incident cardiovascular disease in a prospective cohort of adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study.
    Shea JW, Jacobs DR, Howard AG, Lulla A, Lloyd-Jones DM, Murthy VL, Shah RV, Trujillo-Gonzalez I, Gordon-Larsen P, Meyer KA.
    Am J Clin Nutr; 2024 Jan 24; 119(1):29-38. PubMed ID: 37865185
    [Abstract] [Full Text] [Related]

  • 12. Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure.
    Iguchi M, Wada H, Shinozaki T, Suzuki M, Ajiro Y, Matsuda M, Koike A, Koizumi T, Shimizu M, Ono Y, Takenaka T, Sakagami S, Morita Y, Fujimoto K, Yonezawa K, Yoshida K, Ninomiya A, Nakamura T, Funada J, Kajikawa Y, Oishi Y, Kato T, Kotani K, Abe M, Akao M, Hasegawa K, PREHOSP-CHF Study Investigators.
    ESC Heart Fail; 2021 Oct 24; 8(5):4187-4198. PubMed ID: 34387398
    [Abstract] [Full Text] [Related]

  • 13. Urinary Levels of Trimethylamine-N-Oxide and Incident Coronary Heart Disease: A Prospective Investigation Among Urban Chinese Adults.
    Yu D, Shu XO, Rivera ES, Zhang X, Cai Q, Calcutt MW, Xiang YB, Li H, Gao YT, Wang TJ, Zheng W.
    J Am Heart Assoc; 2019 Jan 08; 8(1):e010606. PubMed ID: 30606084
    [Abstract] [Full Text] [Related]

  • 14. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA, Barnard D, Clare R, Ellis SJ, Fleg JL, Fonarow GC, Franklin BA, Kilpatrick RD, Kitzman DW, O'Connor CM, Piña IL, Thadani U, Thohan V, Whellan DJ, HF-ACTION Investigators.
    Clin Cardiol; 2013 Oct 08; 36(10):611-20. PubMed ID: 23929781
    [Abstract] [Full Text] [Related]

  • 15. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
    Kaysen GA, Johansen KL, Chertow GM, Dalrymple LS, Kornak J, Grimes B, Dwyer T, Chassy AW, Fiehn O.
    J Ren Nutr; 2015 Jul 08; 25(4):351-6. PubMed ID: 25802017
    [Abstract] [Full Text] [Related]

  • 16. Increased serum S100A12 levels are associated with higher risk of acute heart failure in patients with type 2 diabetes.
    Gellen B, Thorin-Trescases N, Thorin E, Gand E, Ragot S, Montaigne D, Pucheu Y, Mohammedi K, Gatault P, Potier L, Liuu E, Hadjadj S, Saulnier PJ, SURDIAGENE Study group.
    ESC Heart Fail; 2022 Dec 08; 9(6):3909-3919. PubMed ID: 36637406
    [Abstract] [Full Text] [Related]

  • 17. Trimethylamine N-oxide and prognosis in acute heart failure.
    Suzuki T, Heaney LM, Bhandari SS, Jones DJ, Ng LL.
    Heart; 2016 Jun 01; 102(11):841-8. PubMed ID: 26869641
    [Abstract] [Full Text] [Related]

  • 18. Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function.
    Sanchez-Gimenez R, Peiró ÓM, Bonet G, Carrasquer A, Fragkiadakis GA, Bulló M, Papandreou C, Bardaji A.
    Front Cardiovasc Med; 2022 Jun 01; 9():1000815. PubMed ID: 36211587
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Associations of serum trimethylamine N-oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort.
    Byrd DA, Zouiouich S, Karwa S, Li XS, Wang Z, Sampson JN, Loftfield E, Huang WY, Hazen SL, Sinha R.
    Cancer; 2024 Jun 01; 130(11):1982-1990. PubMed ID: 38285606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.